Company Overview of Fidia Farmaceutici s.p.a.
Fidia Farmaceutici s.p.a. researches, develops, manufactures, markets, and sells medicinal products, medical devices, and dietary supplements primarily based on hyaluronic acid and its derivatives. The company’s primary business areas include treatment and management of joint care/musculoskeletal disorders, including osteoarthritis, and advanced wound care/dermo-aesthetics. The company offers dietary supplements, hyaluronic acid sodium salts, diclofenac sodium salts, gingival gels, hyaluronic acid sodium salt for intra-dermal administration, auto cross-linked hyaluronic acid for intra-dermal administration, vaginal bioequilibrant gels, topical gels, cream-impregnated gauze pads for topical u...
Via Ponte della Fabbrica 3/A
Abano Terme, PD 35031
Founded in 1946
Key Executives for Fidia Farmaceutici s.p.a.
Compensation as of Fiscal Year 2015.
Fidia Farmaceutici s.p.a. Key Developments
Fidia Farmaceutici Signs Partnership Agreement with APR Applied Pharma Research to Market APR Paediatric Products in Italy
Jul 3 15
Fidia Farmaceutici and APR Applied Pharma Research have entered into a partnership agreement allowing Fidia to market APR paediatric products in Italy. Under the terms of the deal, Fidia will be granted rights to commercialize APR's global over-the-counter (OTC) and prescription brand, Halykoo, which caters for a range of paediatric skin and mucosal health treatments. The Halykoo brand will be available in Italy from 2016. The partnership complements Fidia's existing therapeutic portfolio in the paediatrics market segment.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries